Analysis of the microglia transcriptome across the human lifespan using single cell RNA sequencing.

Ex vivo human microglia Gene regulatory network Transcriptional heterogeneity scRNA-seq

Journal

Journal of neuroinflammation
ISSN: 1742-2094
Titre abrégé: J Neuroinflammation
Pays: England
ID NLM: 101222974

Informations de publication

Date de publication:
30 May 2023
Historique:
received: 29 05 2022
accepted: 17 05 2023
medline: 1 6 2023
pubmed: 31 5 2023
entrez: 30 5 2023
Statut: epublish

Résumé

Microglia are tissue resident macrophages with a wide range of critically important functions in central nervous system development and homeostasis. In this study, we aimed to characterize the transcriptional landscape of ex vivo human microglia across different developmental ages using cells derived from pre-natal, pediatric, adolescent, and adult brain samples. We further confirmed our transcriptional observations using ELISA and RNAscope. We showed that pre-natal microglia have a distinct transcriptional and regulatory signature relative to their post-natal counterparts that includes an upregulation of phagocytic pathways. We confirmed upregulation of CD36, a positive regulator of phagocytosis, in pre-natal samples compared to adult samples in situ. Moreover, we showed adult microglia have more pro-inflammatory signature compared to microglia from other developmental ages. We indicated that adult microglia are more immune responsive by secreting increased levels of pro-inflammatory cytokines in response to LPS treatment compared to the pre-natal microglia. We further validated in situ up-regulation of IL18 and CXCR4 in human adult brain section compared to the pre-natal brain section. Finally, trajectory analysis indicated that the transcriptional signatures adopted by microglia throughout development are in response to a changing brain microenvironment and do not reflect predetermined developmental states. In all, this study provides unique insight into the development of human microglia and a useful reference for understanding microglial contribution to developmental and age-related human disease.

Sections du résumé

BACKGROUND BACKGROUND
Microglia are tissue resident macrophages with a wide range of critically important functions in central nervous system development and homeostasis.
METHOD METHODS
In this study, we aimed to characterize the transcriptional landscape of ex vivo human microglia across different developmental ages using cells derived from pre-natal, pediatric, adolescent, and adult brain samples. We further confirmed our transcriptional observations using ELISA and RNAscope.
RESULTS RESULTS
We showed that pre-natal microglia have a distinct transcriptional and regulatory signature relative to their post-natal counterparts that includes an upregulation of phagocytic pathways. We confirmed upregulation of CD36, a positive regulator of phagocytosis, in pre-natal samples compared to adult samples in situ. Moreover, we showed adult microglia have more pro-inflammatory signature compared to microglia from other developmental ages. We indicated that adult microglia are more immune responsive by secreting increased levels of pro-inflammatory cytokines in response to LPS treatment compared to the pre-natal microglia. We further validated in situ up-regulation of IL18 and CXCR4 in human adult brain section compared to the pre-natal brain section. Finally, trajectory analysis indicated that the transcriptional signatures adopted by microglia throughout development are in response to a changing brain microenvironment and do not reflect predetermined developmental states.
CONCLUSION CONCLUSIONS
In all, this study provides unique insight into the development of human microglia and a useful reference for understanding microglial contribution to developmental and age-related human disease.

Identifiants

pubmed: 37254100
doi: 10.1186/s12974-023-02809-7
pii: 10.1186/s12974-023-02809-7
pmc: PMC10230780
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

132

Informations de copyright

© 2023. The Author(s).

Références

Neuron. 2019 Jan 16;101(2):207-223.e10
pubmed: 30606613
Bioinformatics. 2012 Mar 15;28(6):882-3
pubmed: 22257669
Brain Nerve. 2014 May;66(5):581-90
pubmed: 24807373
J Biol Chem. 2016 Sep 30;291(40):21271-21282
pubmed: 27539853
J Exp Med. 2018 Sep 3;215(9):2235-2245
pubmed: 30082275
Nat Neurosci. 2014 Jan;17(1):131-43
pubmed: 24316888
EMBO J. 2017 Nov 15;36(22):3292-3308
pubmed: 28963396
Front Immunol. 2020 Jun 03;11:947
pubmed: 32582147
Nat Methods. 2017 Sep 29;14(10):935-936
pubmed: 28960196
Cell Rep. 2017 Oct 10;21(2):366-380
pubmed: 29020624
Cardiovasc Res. 2017 Sep 01;113(11):1376-1388
pubmed: 28859294
Nature. 2019 Feb;566(7744):388-392
pubmed: 30760929
Trends Cell Biol. 2016 Aug;26(8):587-597
pubmed: 27004698
J Neurosci. 2004 Mar 3;24(9):2236-46
pubmed: 14999074
Cell Stem Cell. 2021 Mar 4;28(3):581-583
pubmed: 33667362
Gigascience. 2018 Jul 1;7(7):
pubmed: 30010766
Immunity. 2019 Jan 15;50(1):253-271.e6
pubmed: 30471926
J Neurosci. 2013 Mar 6;33(10):4216-33
pubmed: 23467340
J Clin Med. 2019 Dec 09;8(12):
pubmed: 31818018
Front Immunol. 2018 May 24;9:1014
pubmed: 29881376
J Clin Invest. 2017 Sep 1;127(9):3220-3229
pubmed: 28758903
Glia. 2020 Apr;68(4):811-829
pubmed: 31724770
Immunol Rev. 2018 Jan;281(1):8-27
pubmed: 29247995
Nat Biotechnol. 2019 Dec;37(12):1482-1492
pubmed: 31796933
Science. 2020 Jul 31;369(6503):530-537
pubmed: 32732419
Nat Neurosci. 2019 Dec;22(12):2098-2110
pubmed: 31740814
Life Sci. 2016 May 1;152:244-8
pubmed: 26596563
Nat Neurosci. 2019 Mar;22(3):374-385
pubmed: 30718903
Immunol Cell Biol. 2017 Aug;95(7):611-619
pubmed: 28303902
Nat Methods. 2017 Nov;14(11):1083-1086
pubmed: 28991892
Science. 2010 Nov 5;330(6005):841-5
pubmed: 20966214
Cells. 2019 May 31;8(6):
pubmed: 31159306
Front Cell Neurosci. 2018 Aug 30;12:282
pubmed: 30214398
Glia. 2022 Oct;70(10):1938-1949
pubmed: 35735919
Science. 2017 Jun 23;356(6344):
pubmed: 28546318
J Immunol. 2016 Apr 15;196(8):3375-84
pubmed: 26962228
Development. 2018 Jul 4;145(13):
pubmed: 29973370
Am J Hum Genet. 2019 May 2;104(5):936-947
pubmed: 30982608
Methods Mol Biol. 2013;1041:199-211
pubmed: 23813381
Science. 2016 Aug 19;353(6301):aad8670
pubmed: 27338705
Mol Psychiatry. 2017 Nov;22(11):1576-1584
pubmed: 27400854
Cell Stem Cell. 2010 Oct 8;7(4):483-95
pubmed: 20887954
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Nat Genet. 2011 Dec 25;44(2):200-5
pubmed: 22197934
Science. 2019 Sep 27;365(6460):
pubmed: 31604244
Science. 2018 Oct 12;362(6411):185-189
pubmed: 30309946
Cell. 1997 May 16;89(4):619-28
pubmed: 9160753
Cell. 2019 Dec 12;179(7):1609-1622.e16
pubmed: 31835035
Dev Cell. 2021 May 3;56(9):1326-1345.e6
pubmed: 33887203
Nat Rev Neurosci. 2018 Oct;19(10):622-635
pubmed: 30206328
J Neurosci Res. 1996 Aug 15;45(4):375-81
pubmed: 8872897
Nat Neurosci. 2022 Mar;25(3):306-316
pubmed: 35260865
Nat Commun. 2019 Jul 3;10(1):2939
pubmed: 31270324

Auteurs

Moein Yaqubi (M)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.

Adam M R Groh (AMR)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.

Marie-France Dorion (MF)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.

Elia Afanasiev (E)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.

Julia Xiao Xuan Luo (JXX)

Department of Microbiology and Immunology, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.

Hadi Hashemi (H)

Department of Electrical and Electronic Engineering, Shiraz University of Technology, Shiraz, Fars, Iran.

Sarthak Sinha (S)

Department of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, AB, Canada.

Nicholas W Kieran (NW)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.

Manon Blain (M)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.

Qiao-Ling Cui (QL)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.

Jeff Biernaskie (J)

Department of Comparative Biology and Experimental Medicine, University of Calgary, Calgary, AB, Canada.

Myriam Srour (M)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Department of Pediatric Neurosurgery, Montreal Children's Hospital, Montreal, QC, Canada.

Roy Dudley (R)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.
Department of Pediatric Neurosurgery, Montreal Children's Hospital, Montreal, QC, Canada.

Jeffery A Hall (JA)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.

Joshua A Sonnen (JA)

Departments of Pathology, Neurology and Neurosurgery, McGill University, Montreal, QC, Canada.

Nathalie Arbour (N)

Neuroimmunology Research Laboratory, Centre de Recherche du Centre Hospitalier de L, Université de Montréal (CRCHUM), Montreal, QC, Canada.
Department of Neurosciences, Université de Montréal, Montreal, QC, Canada.

Alexandre Prat (A)

Department of Neurosciences, Université de Montréal, Montreal, QC, Canada.

Jo Anne Stratton (JA)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.

Jack Antel (J)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada.

Luke M Healy (LM)

Neuroimmunology Unit, Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, McGill University, Montreal, QC, Canada. luke.healy@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH